- Home
- NVCR vs CRTO Comparison
NVCR vs CRTO Comparison
Compare NVCR & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- CRTO
- Stock Information
- Founded
- NVCR 2000
- CRTO 2005
- Country
- NVCR Switzerland
- CRTO France
- Employees
- NVCR N/A
- CRTO N/A
- Industry
- NVCR Medical/Dental Instruments
- CRTO Advertising
- Sector
- NVCR Health Care
- CRTO Consumer Discretionary
- Exchange
- NVCR Nasdaq
- CRTO Nasdaq
- Market Cap
- NVCR 1.9B
- CRTO 1.4B
- IPO Year
- NVCR 2015
- CRTO 2013
- Fundamental
- Price
- NVCR $17.02
- CRTO $23.15
- Analyst Decision
- NVCR Buy
- CRTO Buy
- Analyst Count
- NVCR 7
- CRTO 11
- Target Price
- NVCR $32.43
- CRTO $44.70
- AVG Volume (30 Days)
- NVCR 1.2M
- CRTO 382.5K
- Earning Date
- NVCR 07-24-2025
- CRTO 07-31-2025
- Dividend Yield
- NVCR N/A
- CRTO N/A
- EPS Growth
- NVCR N/A
- CRTO 107.32
- EPS
- NVCR N/A
- CRTO 2.44
- Revenue
- NVCR $621,711,000.00
- CRTO $1,934,668,000.00
- Revenue This Year
- NVCR $5.44
- CRTO N/A
- Revenue Next Year
- NVCR $9.05
- CRTO $1.96
- P/E Ratio
- NVCR N/A
- CRTO $9.70
- Revenue Growth
- NVCR 18.27
- CRTO N/A
- 52 Week Low
- NVCR $14.17
- CRTO $23.17
- 52 Week High
- NVCR $34.13
- CRTO $49.93
- Technical
- Relative Strength Index (RSI)
- NVCR 47.92
- CRTO 37.05
- Support Level
- NVCR $17.33
- CRTO $23.60
- Resistance Level
- NVCR $18.59
- CRTO $25.37
- Average True Range (ATR)
- NVCR 0.69
- CRTO 0.66
- MACD
- NVCR 0.01
- CRTO 0.10
- Stochastic Oscillator
- NVCR 31.44
- CRTO 7.75
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.